Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.48 |
| ▸ | ACACA | Q13085 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13106363 | 1.00 | ACACB (0.48) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL211871 | 0.94 | ACACB (0.53) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL186814 | 0.94 | ACACB (0.53) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL13106362 | 0.94 | ACACB (0.39) | ACACBACACA | |
| SCHEMBL10257266 | 0.94 | ACACB (0.53) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL186512 | 0.94 | ACACB (0.53) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL186531 | 0.92 | ACACB (0.50) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL13106111 | 0.87 | ACACB (0.43) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL22819360 | 0.87 | ACACB (0.59) | ACACBACACAFFAR1CPT2TDP1 | |
| SCHEMBL6178291 | 0.87 | ACACB (0.59) | ACACBACACAFFAR1CPT2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402300-A1 | Hydroxyl compounds and compositions for cholesterol management and related uses | Esperion Therapeutics Inc. (US) | 2012-01-04 | — | — | EP | disclosed |